Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction.
暂无分享,去创建一个
H Yasue | K. Nakao | K. Kugiyama | H. Ogawa | H. Yasue | Y. Miyamoto | Y Ogawa | Y Miyamoto | M Yoshimura | K Nakao | Y Saito | Y. Saito | M. Nakayama | M. Yoshimura | Y. Shimasaki | Y. Ogawa | E. Harada | K Kugiyama | K. Nakao | Y Shimasaki | M Nakayama | H Ogawa | E Harada | T Masuda | W Koyama | E. Harada | T. Masuda | W. Koyama | Yoshihiko Saito | Yoshihiro Miyamoto
[1] C. D. Barry,et al. Comparison of predicted and experimentally determined secondary structure of adenyl kinase , 1974, Nature.
[2] K. Nakao,et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese , 1998, Human Genetics.
[3] A. Gardemann,et al. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. , 1995, Circulation.
[4] Aravinda Chakravarti,et al. Methodology in medical genetics: An introduction to statistical methods , 1988 .
[5] L. Baumgartner. "We Need Each Other". , 1957, American journal of public health and the nation's health.
[6] A. Maxwell,et al. ACE gene typing , 1994, The Lancet.
[7] A. Morice,et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. , 1996, Journal of the American College of Cardiology.
[8] Henry A. Erlich,et al. Enzymatic amplification of ?-globin genomic sequences and restriction site analysis for diagnosis of , 1985 .
[9] K. Schappert,et al. Molecular cloning and characterization of human endothelial nitric oxide synthase , 1992, FEBS letters.
[10] J M Lalouel,et al. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. , 1995, Circulation.
[11] W. Kannel,et al. Clinical misconceptions dispelled by epidemiological research. , 1995, Circulation.
[12] F. Soubrier,et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.
[13] A. Hassid,et al. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[14] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[15] S. Scherer,et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. , 1993, The Journal of biological chemistry.
[16] T. Quertermous,et al. Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.
[17] A. Maseri,et al. Coronary artery spasm and vasoconstriction. The case for a distinction. , 1990, Circulation.
[18] P. Tempst,et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Conti. Coronary-artery spasm and myocardial infarction. , 1983, The New England journal of medicine.
[20] T. Dawber,et al. II. Coronary Heart Disease in the Framingham Study , 1957 .
[21] T. Quertermous,et al. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.
[22] H. Yasue,et al. Coronary Arterial Spasm in Ischemic Heart Disease and Its Pathogenesis: A Review , 1983, Circulation research.
[23] P. Tsao,et al. Is NO an endogenous antiatherogenic molecule? , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[25] R. Badenhop,et al. A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.
[26] L. Tiret,et al. Departure from Hardy-Weinberg equilibrium should be systematically tested in studies of association between genetic markers and disease. , 1995, Circulation.
[27] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[28] Ancel Keys. Coronary heart disease in seven countries. , 1971, The Medical journal of Australia.
[29] A. M. Lefer,et al. Nitric oxide: nature's naturally occurring leukocyte inhibitor. , 1997, Circulation.
[30] M J Peach,et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. , 1992, The Journal of biological chemistry.
[31] T. Dawber,et al. Coronary heart disease in the Framingham study. , 1957, American journal of public health and the nation's health.
[32] J. Erikssen,et al. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction , 1993, Clinical genetics.
[33] K. Okumura,et al. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. , 1992, Journal of the American College of Cardiology.
[34] U. Walter,et al. NO at work , 1994, Cell.
[35] J. Loscalzo,et al. Nitric oxide and its role in the cardiovascular system. , 1995, Progress in cardiovascular diseases.
[36] E. Braunwald,et al. Coronary-artery spasm. , 1978, The New England journal of medicine.
[37] A. Emery. Methodology in medical genetics: An introduction to statistical methods , 1976 .
[38] A. Gotto. Interactions of the major risk factors for coronary heart disease. , 1986, The American journal of medicine.
[39] T. Michel,et al. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. , 1995, Life sciences.
[40] R Kreutz,et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.